PRKCA and acute lymphoblastic leukemia: To evaluate PKCα potential as a prognostic biomarker, we investigated the association of PKCα mRNA expression levels with prognosis in a representative cohort of pediatric T-ALL patients treated in AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) centers.